{"id":"palifermin-before-and-after","safety":{"commonSideEffects":[{"rate":null,"effect":"Dysgeusia (altered taste)"},{"rate":null,"effect":"Mouth/tongue thickness"},{"rate":null,"effect":"Rash"},{"rate":null,"effect":"Edema"}]},"_chembl":{"chemblId":"CHEMBL1201821","moleculeType":"Protein"},"_dailymed":null,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"Palifermin binds to and activates the fibroblast growth factor receptor 2 (FGFR2), which is expressed on epithelial cells lining the oral cavity and gastrointestinal tract. This activation promotes cell proliferation, differentiation, and migration, enhancing the protective barrier function of the mucosa and reducing the severity and duration of chemotherapy-induced oral mucositis.","oneSentence":"Palifermin is a keratinocyte growth factor (KGF) receptor agonist that stimulates epithelial cell proliferation and differentiation to protect and repair oral mucosa.","_ai_confidence":"medium"},"_scrapedAt":"2026-03-28T01:25:24.745Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Chemotherapy-induced oral mucositis in patients receiving myeloablative chemotherapy followed by hematopoietic stem cell transplantation"}]},"trialDetails":[{"nctId":"NCT01306019","phase":"PHASE1, PHASE2","title":"Lentiviral Gene Transfer for Treatment of Children Older Than Two Years of Age With X-Linked Severe Combined Immunodeficiency (XSCID)","status":"RECRUITING","sponsor":"National Institute of Allergy and Infectious Diseases (NIAID)","startDate":"2012-09-25","conditions":"X-linked Severe Combined Immunodeficiency (XSCID)","enrollment":40},{"nctId":"NCT06959771","phase":"PHASE1, PHASE2","title":"Base Editing Hematopoietic Stem Cell and T Cell Gene Therapy for CD40L-HyperIgM Syndrome: Single Patient Study","status":"RECRUITING","sponsor":"National Institute of Allergy and Infectious Diseases (NIAID)","startDate":"2025-07-16","conditions":"CD40L-HyperIgM Syndrome","enrollment":1},{"nctId":"NCT06325709","phase":"PHASE1, PHASE2","title":"Base Editing for Mutation Repair in Hematopoietic Stem & Progenitor Cells for X-Linked Chronic Granulomatous Disease","status":"RECRUITING","sponsor":"National Institute of Allergy and Infectious Diseases (NIAID)","startDate":"2024-04-17","conditions":"Chronic Granulomatous Disease (CGD), X-Linked Chronic Granulomatous Disease","enrollment":10},{"nctId":"NCT06859424","phase":"PHASE2","title":"A Platform Protocol to Investigate Post-Transplant Cyclophosphamide-Based Graft-Versus-Host Disease Prophylaxis in Patients With Hematologic Malignancies Undergoing Mismatched Unrelated Donor Peripheral Blood Stem Cell Transplantation","status":"RECRUITING","sponsor":"Center for International Blood and Marrow Transplant Research","startDate":"2025-07-25","conditions":"AML (Acute Myelogenous Leukemia), Acute Lymphoid Leukemia (ALL), Acute Leukemia (Category)","enrollment":358},{"nctId":"NCT06851767","phase":"PHASE1, PHASE2","title":"Base-Edited Hematopoietic Stem/Progenitor Cell X-Linked Severe Combined Immunodeficiency Gene Therapy","status":"ENROLLING_BY_INVITATION","sponsor":"National Institute of Allergy and Infectious Diseases (NIAID)","startDate":"2025-05-09","conditions":"X-linked Severe Combined Immunodeficiency, X-SCID, XSCID","enrollment":18},{"nctId":"NCT01746849","phase":"PHASE2","title":"Palifermin With Leuprolide Acetate for the Promotion of Immune Recovery Following Total Body Irradiation Based T-Cell Depleted Allogeneic Hematopoietic Stem Cell Transplantation","status":"ACTIVE_NOT_RECRUITING","sponsor":"Memorial Sloan Kettering Cancer Center","startDate":"2012-12","conditions":"Leukemia, Multiple Myeloma, Myelodysplastic Syndrome","enrollment":82},{"nctId":"NCT01085617","phase":"","title":"Standard Chemotherapy with or Without Nelarabine or Rituximab in Treating Patients with Newly Diagnosed Acute Lymphoblastic Leukemia","status":"COMPLETED","sponsor":"University College, London","startDate":"2010-12","conditions":"Leukemia, Mucositis, Oral Complications","enrollment":""},{"nctId":"NCT00629798","phase":"PHASE2","title":"Busulfan, Melphalan, and Fludarabine With Peri-transplant Palifermin, Followed by a T-Cell Depleted Hematopoietic Stem Cell Transplant From HLA Matched or Mismatched Related or Unrelated Donors in Patients With Advanced Myelodysplastic Syndromes (MDS) and Acute Myeloid Leukemia (AML)","status":"COMPLETED","sponsor":"Memorial Sloan Kettering Cancer Center","startDate":"2008-02-12","conditions":"Acute Myeloid Leukemia, Advanced Myelodysplastic Syndromes","enrollment":64},{"nctId":"NCT01712945","phase":"PHASE1, PHASE2","title":"Keratinocyte Growth Factor to Prevent Autoimmunity After Alemtuzumab Treatment of Multiple Sclerosis","status":"TERMINATED","sponsor":"Cambridge University Hospitals NHS Foundation Trust","startDate":"2012-06","conditions":"Multiple Sclerosis","enrollment":40},{"nctId":"NCT00728585","phase":"PHASE2","title":"Palifermin in Preventing Oral Mucositis Caused by Chemotherapy and/or Radiation Therapy in Young Patients Undergoing Stem Cell Transplant","status":"WITHDRAWN","sponsor":"Children's Oncology Group","startDate":"2008-03-13","conditions":"Gastrointestinal Mucositis, Malignant Neoplasm","enrollment":""},{"nctId":"NCT00360971","phase":"PHASE3","title":"Palifermin in Lessening Oral Mucositis in Patients Undergoing Radiation Therapy and Chemotherapy for Locally Advanced Head and Neck Cancer","status":"TERMINATED","sponsor":"Radiation Therapy Oncology Group","startDate":"2006-07","conditions":"Head and Neck Cancer, Mucositis, Pain","enrollment":21},{"nctId":"NCT02653196","phase":"EARLY_PHASE1","title":"A Multi-Institutional Pilot Study of Allogeneic Hematopoietic Stem Cell Transplantation for Patients With Malignant Neuro-Epithelial and Other Solid Tumors","status":"TERMINATED","sponsor":"Montefiore Medical Center","startDate":"2015-09","conditions":"Neuroepithelial Tumor, Solid Tumor, Allogeneic Hematopoietic Stem Cell Transplantation","enrollment":1},{"nctId":"NCT00626639","phase":"PHASE1, PHASE2","title":"A Study of Palifermin for the Reduction of Oral Mucositis in Patients With Locally Advanced Head and Neck Cancer Receiving Postoperative Radiotherapy and Concurrent Chemotherapy","status":"COMPLETED","sponsor":"Swedish Orphan Biovitrum","startDate":"2005-07","conditions":"Mucositis, Head and Neck Cancer","enrollment":5},{"nctId":"NCT02961816","phase":"PHASE2","title":"Panobinostat Combined With High-Dose Gemcitabine/Busulfan/Melphalan With Autologous Stem Cell Transplant for Patients With Refractory/Relapsed Lymphoma","status":"WITHDRAWN","sponsor":"M.D. Anderson Cancer Center","startDate":"2017-06","conditions":"Lymphoma","enrollment":""},{"nctId":"NCT01421173","phase":"PHASE1","title":"Vorinostat With Gemcitabine, Busulfan, and Melphalan With Stem Cell Transplant (SCT) in Relapsed or Refractory Lymphoid Malignancies","status":"COMPLETED","sponsor":"M.D. Anderson Cancer Center","startDate":"2011-08","conditions":"Lymphoma","enrollment":78},{"nctId":"NCT00434161","phase":"PHASE3","title":"A Study of Palifermin for the Reduction of Oral Mucositis in Subjects With Multiple Myeloma","status":"COMPLETED","sponsor":"Swedish Orphan Biovitrum","startDate":"2006-12","conditions":"Multiple Myeloma","enrollment":281},{"nctId":"NCT02313792","phase":"PHASE3","title":"Palifermin for Patients Receiving Hematopoietic Stem Cell Transplantation","status":"UNKNOWN","sponsor":"The Catholic University of Korea","startDate":"2015-01","conditions":"Mucositis","enrollment":88},{"nctId":"NCT00460421","phase":"PHASE1","title":"A Phase 1 Dose-escalation Study to Evaluate the Safety and Pharmacokinetics (PK) of Palifermin in Subjects With Acute Leukemias Undergoing HSCT","status":"COMPLETED","sponsor":"Swedish Orphan Biovitrum","startDate":"2006-08","conditions":"Leukemia","enrollment":27},{"nctId":"NCT00352703","phase":"PHASE4","title":"PROMPT - Palifermin in Reduction of Oral Mucositis in PBSC Transplantation","status":"COMPLETED","sponsor":"Swedish Orphan Biovitrum","startDate":"2006-04","conditions":"Non-Hodgkin's Lymphoma, Multiple Myeloma","enrollment":145},{"nctId":"NCT00070616","phase":"PHASE1","title":"Pharmacokinetic Study of Palifermin in Subjects Receiving Radiation Therapy and Chemotherapy Followed by Blood Stem Cell Support","status":"COMPLETED","sponsor":"Swedish Orphan Biovitrum","startDate":"2001-12","conditions":"Leukemia, Lymphoma, Myeloma","enrollment":25},{"nctId":"NCT00189488","phase":"PHASE2","title":"Trial to Evaluate Palifermin in the Reduction of Acute Graft Versus Host Disease in Patients With Hematologic Malignancies Undergoing Allogeneic Marrow/Peripheral Blood Progenitor Cell (PBPC) Transplantation","status":"COMPLETED","sponsor":"Swedish Orphan Biovitrum","startDate":"2005-12","conditions":"Graft Versus Host Disease, Hematologic Malignancies","enrollment":155},{"nctId":"NCT00109031","phase":"PHASE3","title":"Palifermin for the Reduction of Oral Mucositis in Single-dose Evaluation (PROMISE)","status":"COMPLETED","sponsor":"Swedish Orphan Biovitrum","startDate":"2005-01","conditions":"Cancer, Lymphoma, Leukemia","enrollment":47},{"nctId":"NCT00570999","phase":"PHASE2","title":"Palifermin After Haploidentical PBSCT","status":"WITHDRAWN","sponsor":"European Society for Blood and Marrow Transplantation","startDate":"2008-02","conditions":"Non-Hodgkin's Lymphoma or Hodgkin's Disease, Acute Leukaemia, Myelodysplastic Syndrome","enrollment":""},{"nctId":"NCT00610818","phase":"","title":"Effect of Palifermin on Skin Tumors in Patients Undergoing Bone Marrow Transplantation","status":"TERMINATED","sponsor":"McGill University Health Centre/Research Institute of the McGill University Health Centre","startDate":"2007-07","conditions":"Skin Rash","enrollment":7}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":0,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":["Kepivance"],"phase":"phase_3","status":"active","brandName":"Palifermin before and after","genericName":"Palifermin before and after","companyName":"Swedish Orphan Biovitrum","companyId":"swedish-orphan-biovitrum","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Palifermin is a keratinocyte growth factor (KGF) receptor agonist that stimulates epithelial cell proliferation and differentiation to protect and repair oral mucosa. Used for Chemotherapy-induced oral mucositis in patients receiving myeloablative chemotherapy followed by hematopoietic stem cell transplantation.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}